3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Rheumatic Diseases -

EULAR welcomes Council action to tackle chronic diseases

Rheumatic DiseasesDec 08, 10

The European League Against Rheumatism (EULAR) welcomes the outcomes of yesterday’s Council of the European Union (EPSCO Council). In its meeting on 7 December, ministers for health adopted Council Conclusions on chronic diseases, in which the Council calls on Member States and the European Commission to adopt concrete, coordinated measures to tackle chronic diseases in Europe. EULAR is pleased to note that the Council Conclusions reflect many of the recommendations made at the 19 October Presidency conference on Rheumatic and Musculoskeletal diseases. The conference was organised jointly by the Presidency and EULAR.

Prof. Paul Emery (EULAR President) highlighted the “political relevance of the Council Conclusions”, as the Council’s position “represents a clear message in favour of concrete initiatives at both EU and national levels, to address chronic diseases. This is particularly important for those disorders which represent a huge burden on our economies and health systems, such as musculoskeletal diseases.” According to Prof. Emery, it is now time to look into innovative approaches at Member States’ level. National action plans targeting musculoskeletal conditions could be an excellent way of making progress.

The Council invites Member States to “further develop patient-centred policies for health promotion, primary prevention and secondary prevention, treatment and care of chronic diseases”. Neil Betteridge, EULAR Vice President PARE (People with Arthritis and Rheumatism in Europe), welcomed this recommendation: “EULAR long ago adopted the call of its patient group members of ‘Nothing about us without us’, meaning that the sort of collaboration between clinicians and patient representatives recommended in the Council Conclusions is already recognised as a key component of managing rheumatic and musculoskeletal diseases optimally. EULAR can be proud that its own best practice in this respect, as well as in the scientific and research fields, has been identified by ministers across Europe as an essential part of the new framework for managing chronic conditions generally”.

The Council Conclusions on “Innovative approaches for chronic diseases in public health and healthcare systems” invite both Member States and the European Commission to discuss and propose actions in the following areas: health promotion and prevention, healthcare management,

research into chronic diseases as well as production and exchange of comparable information on chronic diseases across Europe. The European Commission is encouraged to support Member States as well as to prioritise chronic diseases in current and future Europe research and action programmes.

Prof. Emery welcomed the Council’s call to integrate chronic diseases as a priority in European programmes: “It is important that EU policy-making sees the longer term needs. The Council’s position is in line with EULAR’s approach. With a view to the EU 2020 goals, we need to invest strategically in an area like musculoskeletal diseases, where much can be gained in return, in terms of quality of life, but also in terms of economic benefit.”

In adopting these Conclusions, the Council of the EU recognises the burden of chronic diseases on people’s lives as well as on the overall society. It also asks for concrete actions from both Member States and EU institutions to address these issues. Member States and the European Commission are called upon to initiate a reflexion process in close dialogue with relevant stakeholders including patients, professionals, healthcare payers and providers, with the aim to optimise responses to the chronic diseases challenge. The Council Conclusions are an outcome of the work done by the Belgian EU Presidency during its six-month term.


Contact: EULAR Press Office
.(JavaScript must be enabled to view this email address)
European League Against Rheumatism

Print Version
comments powered by Disqus

  New theory on genesis of osteoarthritis comes with successful therapy in mice
  RA Patients Get Cancer Screens, May Need More
  Obesity negatively predicts minimal disease activity achievement in patients with PSA
  Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
  Researchers Find Epidural Steroid Injections Do Not Benefit Spine Patients
  Rituximab combined with a TNF inhibitor and methotrexate shows no safety signal in RA treatment
  Statins Not Routinely Indicated for Children and Adolescents with Lupus
  Combination of Methotrexate and Prednisone Produces Remission In People with Newly-Developed Rheumatoid Arthritis and Undifferentiated Arthritis
  Tai Chi Relieves Arthritis Pain, Improves Reach, Balance, Well-Being
  Fybromyalgia Symptoms Can Vary Widely By admin
  Obesity, Alcohol Among Factors Linked to Women’s Gout Risk
  Moderate drinking may slow arthritis progression


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site